Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase

Authors

  • Hyun-Jung Byun,

    1. Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Sung-Buk Ku, Anam-Dong, Seoul 136-701, South Korea
    2. Department of Microbiology and Immunology, School of Medicine, Hanyang University, Seoul 133-791, South Korea
    Search for more papers by this author
    • These authors contributed equally to this study.

  • Woon-Won Jung,

    1. MyGene Bioscience Institute, Seoul 405-847, South Korea
    Search for more papers by this author
    • These authors contributed equally to this study.

  • Dong-Sup Lee,

    1. Laboratory of Immunology, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, South Korea
    Search for more papers by this author
  • Sanghee Kim,

    1. Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 110-799, South Korea
    Search for more papers by this author
  • Sang Joon Kim,

    1. Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, South Korea
    Search for more papers by this author
  • Chung-Gyu Park,

    1. Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 110-799, South Korea
    Search for more papers by this author
  • Hee Yong Chung,

    1. Department of Microbiology and Immunology, School of Medicine, Hanyang University, Seoul 133-791, South Korea
    Search for more papers by this author
  • Taehoon Chun

    Corresponding author
    1. Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Sung-Buk Ku, Anam-Dong, Seoul 136-701, South Korea
    Search for more papers by this author

Corresponding author. Tel.: +82 2 3290 3069; fax: +82 2 3290 3507. tchun@korea.ac.kr

Abstract

Upon antigenic stimulation, CD1d-restricted NKT cells quickly secrete large amounts of cytokines. This prompt response demonstrates that CD1d-restricted NKT cells may potentially prove to be useful therapeutic agents for the treatment of many diseases. Despite the clinical importance of CD1d-restricted NKT cells, the regulating mechanisms of this unique T cell population remain to be defined. We found murine LAG-3 is inducible on CD1d-restricted NKT cells as the result of a variety of stimulants such as concanavalin A (con A) and anti-CD3. Also, antigen-specific CD1d stimulation can elicit LAG-3 in CD1d-restricted NKT cells. Moreover, ectopic LAG-3 expression on CD1d-restricted NKT cells results in cell cycle arrest in the S phase. These results show that LAG-3 signaling on activated CD1d-restricted NKT cells may down-modulate NKT cell proliferation.

Ancillary